John Dillon
University of Dundee
H-index: 61
Europe-United Kingdom
Top articles of John Dillon
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The iDiabetes Platform: Enhanced Phenotyping of Patients with Diabetes for Precision Diagnosis, Prognosis and Treatment-study protocol for a cluster-randomised controlled study | medRxiv | YeunYi Lin Damien Leith Michael Abbott Rachael Barrett Samira Bell | 2024 |
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis | Plos one | Marc Gurun Paul Brennan Sava Handjiev Aseil Khatib Damien Leith | 2024/4/16 |
Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT | Annals of Hepatology | Jeremy Lee Christopher J Byrne Paul N Brennan Iain MacPherson Eleanor Dow | 2024/3/1 |
Implementation of a liver health check in people with type 2 diabetes | Kushala WM Abeysekera Luca Valenti Zobair Younossi John F Dillon Alina M Allen | 2024/1/1 | |
Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in Tayside, Scotland | Behavioral Medicine | Amy Malaguti Christopher J Byrne Fabio Sani Kevin Power Ann Eriksen | 2024/4/2 |
Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysis | Mark J Hayes Emma Beavon Michael W Traeger John F Dillon Andrew Radley | 2024/3/1 | |
Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm | Gut | Paul N Brennan Shira Zelber-Sagi Alina M Allen John F Dillon Jeffrey V Lazarus | 2024/4/1 |
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice | Paul N Brennan Oliver D Tavabie Wenhao Li Thomas Marjot Lynsey Corless | 2024/2/27 | |
The Enhanced Liver Fibrosis (ELF) score predicts hepatic decompensation and mortality | JHEP Reports | Madeline Pearson Jennifer Nobes Iain Macpherson Lucy Gold Michael Miller | 2024/3/11 |
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions | Alison D Marshall Alex R Willing Abe Kairouz Evan B Cunningham Alice Wheeler | 2024/2/14 | |
Long-term risk factors for developing Barrett’s oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study | BMJ Open Gastroenterology | Christopher J Byrne Paul Brennan James Carberry James Cotton John F Dillon | 2024/3/1 |
A transient positive association between direct‐acting antiviral therapy for hepatitis C infection and drug‐related hospitalization among people who inject drugs: Self … | Addiction | Scott A McDonald Matthew Hickman John F Dillon Alan Yeung Andrew McAuley | 2024/2 |
Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK | International Journal of Drug Policy | Pantelis Samartsidis Ross Harris John Dillon Monica Desai Graham Foster | 2024/4/17 |
Defining characteristics and outcomes for patients with non-alcoholic fatty liver disease admitted to hospital with decompensated cirrhosis | Journal of Hepatology | Oliver D Tavabie Jane Abbott Kushala WM Abeysekera Vinay K Balachandrakumar Kris Bennett | 2023/10/1 |
# FGDebate: Should we focus on detecting patients at risk of liver disease in the community? | Kushala WM Abeysekera Jessica Shearer Oliver D Tavabie John F Dillon Ian A Rowe | 2023/7/1 | |
A multistakeholder approach to innovations in NAFLD care | Communications medicine | Jörn M Schattenberg Alina M Allen Helen Jarvis Shira Zelber-Sagi Ken Cusi | 2023/1/3 |
Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison | BMJ open | Christopher J Byrne Amy Malaguti Sarah Karen Inglis John F Dillon | 2023/4/1 |
A global research priority agenda to advance public health responses to fatty liver disease | Journal of hepatology | Jeffrey V Lazarus Henry E Mark Alina M Allen Juan Pablo Arab Patrizia Carrieri | 2023/9/1 |
O22 High enhanced liver fibrosis (ELF) scores predict acute hepatic decompensation, liver-related mortality and all-cause mortality | Madeline Pearson Jennifer Nobes Lucy Gold Iain Macpherson Michael Miller | 2023/6/1 | |
Transformation of identity in substance use as a pathway to recovery and the potential of treatment for hepatitis C: a systematic review | Sarah R Donaldson Andrew Radley John F Dillon | 2023/3 |
Co-Authors
